Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia
- 16 February 2021
- Vol. 71 (2), 296-308
- https://doi.org/10.1136/gutjnl-2020-323664
Abstract
Objective Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of pancreatic β-cells producing insulin. Both T1D patients and animal models exhibit gut microbiota and mucosa alterations, although the exact cause for these remains poorly understood. We investigated the production of key cytokines controlling gut integrity, the abundance of segmented filamentous bacteria (SFB) involved in the production of these cytokines, and the respective role of autoimmune inflammation and hyperglycaemia. Design We used several mouse models of autoimmune T1D as well as mice rendered hyperglycaemic without inflammation to study gut mucosa and microbiota dysbiosis. We analysed cytokine expression in immune cells, epithelial cell function, SFB abundance and microbiota composition by 16S sequencing. We assessed the role of anti-tumour necrosis factor α on gut mucosa inflammation and T1D onset. Results We show in models of autoimmune T1D a conserved loss of interleukin (IL)-17A, IL-22 and IL-23A in gut mucosa. Intestinal epithelial cell function was altered and gut integrity was impaired. These defects were associated with dysbiosis including progressive loss of SFB. Transfer of diabetogenic T-cells recapitulated these gut alterations, whereas induction of hyperglycaemia with no inflammation failed to do so. Moreover, anti-inflammatory treatment restored gut mucosa and immune cell function and dampened diabetes incidence. Conclusion Our results demonstrate that gut mucosa alterations and dysbiosis in T1D are primarily linked to inflammation rather than hyperglycaemia. Anti-inflammatory treatment preserves gut homeostasis and protective commensal flora reducing T1D incidence.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-11-IDEX-0005-02, Laboratory of Excellence INFL)
- Juvenile Diabetes Research Foundation International (2-SRA-2019-844-S-B)
- Fondation pour la Recherche Médicale (DEQ20140329520 and EQU201903007779)
- Institut National de la Santé et de la Recherche Médicale (N/A)
- European Foundation for the Study of Diabetes (N/A)
- Ministère de l'Enseignement Supérieur et de la Recherche Scientifique (N/A)
This publication has 61 references indexed in Scilit:
- Gender Bias in Autoimmunity Is Influenced by MicrobiotaImmunity, 2013
- Celiac disease in T1DM—the need to look long termNature Reviews Endocrinology, 2011
- Defective Differentiation of Regulatory FoxP3+ T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 DiabetesDiabetes, 2011
- Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic miceProceedings of the National Academy of Sciences of the United States of America, 2011
- Inflammatory Tendencies and Overproduction of IL-17 in the Colon of Young NOD Mice Are Counteracted With Diet ChangeDiabetes, 2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseThe New England Journal of Medicine, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell ResponsesImmunity, 2009
- A novel high-affinity peptide antagonist to the insulin receptorBiochemical and Biophysical Research Communications, 2008
- Enteropathy precedes type 1 diabetes in the BB ratGut, 2004